News

Takeda announced today that the European Commission has approved FRUZAQLA as a monotherapy for the treatment of adults with metastatic colorectal cancer (mCRC) who have previously undergone standard therapies

Sanofi and Biovac, a South African biopharmaceutical company based in Cape Town, have announced a partnership to manufacture inactivated polio vaccines (IPV) locally in Africa. This collaboration

Kyverna Therapeutics, Inc. has received clearance from the U.S. Food and Drug Administration for its Investigational New Drug application concerning KYV-101, an autologous, fully human anti-CD19 chimeric antigen receptor

Sobi® has received approval from the European Commission for ALTUVOCT™, a replacement therapy designed for treating and preventing bleeds, as well as for perioperative prophylaxis in individuals with hemophilia

The CMT Research Foundation, committed to finding treatments for Charcot-Marie-Tooth disease (CMT), has teamed up with ReviR Therapeutics. Their collaboration aims to develop small molecule therapies

AbbVie has announced that the U.S. Food and Drug Administration has approved SKYRIZI® for adults suffering from moderately to severely active ulcerative colitis. This marks the first approval

Assembly Biosciences, Inc., a biotechnology company specializing in novel therapies for serious viral diseases, has announced the commencement of dosing for the Phase 1b trial of ABI-4334

Johnson & Johnson has filed a Biologics License Application with the U.S. Food and Drug Administration for a fixed combination of amivantamab and recombinant human hyaluronidase intended

SpineThera, Inc., a company specializing in long-acting injectable technologies, has announced a new partnership with Mayo Clinic to develop treatments aimed at improving outcomes for those with substance abuse disorders.

UMC Utrecht has started its initial enrollment for a study focused on discovering biomarkers for Amyotrophic Lateral Sclerosis. This research, led by Professor Dr. Leonard van den Berg